| Literature DB >> 30108470 |
Aisha Siddiquah1, Syed Salman Hashmi1, Sadaf Mushtaq1, Sullivan Renouard2, Jean Philippe Blondeau3, Rashda Abbasi4, Christophe Hano2, Bilal Haider Abbasi1,2.
Abstract
Little is known about biogenically synthesized Zinc oxide nanoparticles (Entities:
Keywords: Isodon rugosus; ZnONP; characterization; nanotoxicity; pH; surface adaptation
Year: 2018 PMID: 30108470 PMCID: PMC6088224 DOI: 10.17179/excli2018-1327
Source DB: PubMed Journal: EXCLI J ISSN: 1611-2156 Impact factor: 4.068
Figure 1(A) Thidiazuron induced callus from stem explant, (B) Estimation of phenolic and flavonoid content in callus extract, (C) UV-Vis spectral analysis of ZnONPs, (D) Optical observation of biogenically synthesized ZnONPs using Isodon rugosus extract, (à) Thidiazuron induced callus extract, (bʹ) reaction mixture of callus derived ZnONPs, (ć) plant extract, (é) reaction mixture of plant derived ZnONPs. After completion of the reaction, presence of white precipitate indicates the synthesis of ZnONPs.
Figure 2XRD and SEM analysis of ZnONPs where (A) XRD image of C-ZnONPs, (B) XRD image of W-ZnONPs, (C) SEM image of C-ZnONPs and (D) SEM image of W-ZnONPs
Abbreviations: C-ZnONPs: callus derived naoparticles, W-ZnONPs whole plant derived nanoparticles
Figure 3Figure 3: EDX analysis ZnONPs showing the purity of zinc and oxygen ions in the samples (A) C-ZnONPs, (B) W-ZnONPs
Table 1Atomic percentage of zinc and oxygen in ZnONPs as obtained from EDX analysis
Figure 4FTIR spectra of powdered samples of (A) C-ZnO NPs, (B) W-ZnO NPs
Figure 5Cytotoxic effects of ZnONPs and extracts on HepG2 cells upon 24 hour treatment with 200 µg/ml concentration. Untreated cells, DMSO (solvent) and Doxorubicin (34 µM) were included as controls. Microscopic images of HepG2 cells (treated and untreated). Magnification = 200X, Scale = 100 µm. (A) Callus extracts (CE). (B) Callus derived ZnONPs (C-ZnONPs). (C) Untreated HepG2 cells. (D) Whole plant extracts (WPE). (E) Whole plant derived ZnONPs (W-ZnONPs). (F) DMSO 1% (negative control). (G) Doxorubicin 34 µM (positive control)
Figure 6Percentage viabilities and inhibition of cells relative to untreated control (Mean ± SD). Each sample was studied in triplicates and experiment was performed twice.
Figure 7Tentative graphical representation of ZnONPs cytotoxicity towards HepG2 cell line. ZnONPs induce cytotoxicity by morphological changes, loss of membrane integrity, cell shrinkage, and reduced cell density which are characteristic features of apoptotic cell formation.
Figure 8Antibacterial evaluation of Plant derived ZnONPs and extract (A-WPE) and Callus derived (B-CE) ZnONPs and extract analysed by disc diffusion method, showing zone of inhibition against two Gram-positive (Staphylococcus epidermidis, Bacillus subtilis) and two Gram-negative bacteria (Klebsiella pneumoniae, Pseudomonas aeruginosa). Zone of inhibition were measured in mm, taking sample concentration 10 mg/mL. Notes: Values (mean ± SD) indicates of three experiments
Abbreviations: Abs, amoxicillin antibiotic; WPE, whole plant extract; W-ZnONPs, whole plant derived zinc oxide nanoparticles; CE, callus extract; C-ZnONPs, callus derived ZnONPs; Zn acetate, zinc acetate dihydrate salt; SD, standard deviation
Table 2Antibacterial activity of CE, WPE, C-ZnO NPs and W-ZnO NPs against two Gram-positive (Staphylococcus epidermidis, Bacillus subtilis) and two Gram-negative (Klebsiella pneumoniae, Pseudomonas aeruginosa) bacteria
Figure 9Diagrammatic representation of ZnONPs cytotoxicity towards human pathogenic bacterial strains depending upon many factors such as shape (transformation of particles as function of pH), production of ROS, dysfunction of bacterial membrane, effect of oxidative stress on DNA, protein, mitochondria (cell death), electrostatic forces, charge surface area, ultimately causing death of microbes